RIVENDELL GROUP LLP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Drug pricing under 340B program; Cancer Patient Protection; Ongoing issues related to the implementation of the Affordable Care Act; Reimbursement and patient access issues associated with CMMI Medicare Part B Drug Payment Model proposal and demo project; Vice President Cancer Moon Shot Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Medicare/Medicaid MMM
Concerns regarding Medicare policies for Part B drugs; Issues related to the 340B Drug discount program; Issues related to 340B; 21st Century Cures Initiative (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); Issues concerning implementation of Patient Protection and Affordable Care Act; Reimbursement and patient access issues associated with CMMI proposed Medicare Part B Drug Payment Model
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.